Navigation Links
MiMedx Announces Record First Quarter 2013 Results

ty payable in MiMedx common stock-5,792,330Convertible Senior Secured Promissory Notes, net-4,012,442Other Liabilities288,438299,762Total liabilities6,258,99915,175,306Stockholders' equity:Preferred stock; $.001 par value; 5,000,000 shares authorized and 0 shares issued and outstanding--Common stock; $.001 par value; 130,000,000 shares authorized; 95,825,353 issued and 95,775,353 outstandingfor 2013 and 88,423,169 issued and 88,373,169 outstanding for 201295,82488,423Additional paid-in capital102,826,48189,627,601Treasury stock (50,000 shares at cost)(25,000)(25,000)Accumulated deficit(71,304,130)(69,683,722)Total stockholders' equity31,593,17520,007,302Total liabilities and stockholders' equity




35,182,608See notes to condensed consolidated financial statements 

MiMedx Group, Inc. and Subsidiaries
Non-GAAP Financial Measures and ReconciliationAs used herein, "GAAP", refers to generally accepted accounting principles in the United States. We use various numerical measures in conference calls, investor meetings and other forums which are or may be considered "Non-GAAP financial measures" under Regulation G. We have provided below for your reference, supplemental financial disclosure for these measures, including the most directly comparable GAAP measure and an associated reconciliation.

Reconciliation of Net Loss to "Adjusted EBITDA" defined as Earnings before Interest, Taxes, Depreciation, Amortization, Impairment of intangibles, Earn-out liability and Share Based Compensation:

 Three Months Ended March 31,20132012Net Loss (Per GAAP)

$ (1,620,408)$(1,093,652)Add back:Income Taxes

50,275-Financing expense associated with beneficial conversion of note payable issued in conjunction  with acquisition

-80,353Financing expense associated with beneficial conversion of Line of Credit with Related Party

-11,423Financing expense associated with benefic

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
2. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
3. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
4. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
5. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
6. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
7. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
8. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
9. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
10. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
11. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
Post Your Comments:
(Date:10/8/2015)... ALS Association, in partnership with Prize4Life, is pleased to ... technology solutions for people living with ALS. ... sclerosis) is a progressive neurodegenerative disease that affects neurons ... Eventually, people with ALS lose the ability to initiate ... paralysis and death within two to five years of ...
(Date:10/8/2015)... ... 2015 , ... Talon Innovations, a provider of Precision Machined Products ... it is one of three finalists for the Minnesota Business magazine’s Manufacturing Award in ... Talon Innovations was recognized as a nominee for this competitive award. , The ...
(Date:10/7/2015)... Mass. , Oct. 7, 2015 ... announced the start of the Boston Scientific Connected ... encourage advancements in the use of remote patient monitoring ... engineers, designers and entrepreneurs can submit their ideas and ... site ( ). Cambridge, MA ...
(Date:10/7/2015)... Oct. 7, 2015  ContraVir Pharmaceuticals, Inc. (Nasdaq: ... focused on the development and commercialization of targeted antiviral ... offering of 5,000,000 shares of its common stock and ... Company,s common stock at a fixed combined price to ... and warrants will be issued separately.  The warrants will ...
Breaking Biology Technology:
... Suggests that Understanding the Fundamental Mechanism of Angiogenesis ... VEGF - AAmgen Launches Angiogenesis Website THOUSAND OAKS, ... AMGN ) today announced that results from several ... be presented at the 2009 American Association for ...
... automating their environmental monitoring processes using MODA-EM™ , ... ... -- The Parenteral Drug Association (PDA) is hosting their annual ... Red Rock Casino and Resort. During this event, MODA Technology ...
... April 16 Cord Blood America, Inc. (OTC Bulletin ... company ( ) focused ... to families nationwide and internationally, said today that revenues ... increased 8.7 percent, or $0.3 million, to $3.4 million ...
Cached Biology Technology:
(Date:9/26/2015)... -- Results of a TactioRPM pilot project in a ... Stanford Medicine X Conference. In a presentation titled ... Devices and Pharmacogenomics", Roger Simard , Pharmacist ... senior patients equipped with connected health devices and ... TactioRPM remote patient monitoring platform were empowered to ...
(Date:9/10/2015)... Sept. 10, 2015 Report Details ... quite delivered upon previous expectations of revenues, consumer adoption ... breakthrough year in which wearables begin to achieve that ... of the main reasons is the entrance of Apple ... the SmartWatches market, but the overall size of the ...
(Date:9/8/2015)... -- Affectiva, global leader in emotion-sensing and analytics, announces ... data solution, and version 2.0 of its emotion-sensing ... and patented science, these new offerings provide unique ... such as market research, gaming, media and entertainment, ... HR, automotive, robotics, healthcare and wearables. ...
Breaking Biology News(10 mins):
... a venture once thought to lie outside the reach ... Israel Deaconess Medical Center have captured and sequenced tiny ... rex. The protein fragments—seven in all—appear to most closely ... day chickens, lending support to a recent and still ...
... disease regardless of the stage at time of diagnosis. ... of ductal adenocarcinoma associated with cystic lesions that can ... 50 percent long-term survival rate. Why cystic ductal pancreatic ... mutations as the more common and deadly type of ...
... mesothelioma ?a form of cancer associated with asbestos exposure ?have ... two cancer drugs, a large multicenter study finds. , Mesothelioma, ... the lining of the lungs, heart and abdomen, is associated ... , In the study, patients receiving pemetrexed and cisplatin ?along ...
Cached Biology News:
Rabbit polyclonal to Factor IX ( Abpromise for all tested applications). entrezGeneID: 2158 SwissProtID: P00740...
Adhesion Molecule Antibodies...
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
Biology Products: